New radiation approach tested for vulnerable liver cancer patients
NCT ID NCT02626312
Summary
This early-stage trial is testing whether a specialized form of radiation therapy is safe for people with liver cancer who also have poor liver function or a reduced amount of healthy liver tissue. The study will enroll 36 patients to find the highest safe dose of radiation that can be given without causing severe side effects. The goal is to see if this treatment can help control cancer in patients who are often not eligible for standard radiation due to their liver condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.